First Gene Therapy for Genetic Hearing Loss, Otarmeni, Gains FDA Approval

MONDAY, April 27, 2026 — In a historic leap for medical science, the U.S. Food and Drug Administration (FDA) has greenlit the first-ever gene therapy to treat a rare form of inherited deafness.
The treatment — called Otarmeni &mdash…

HC

فريق هلا كير الطبي

محتوى طبي موثوق من مصادر عالمية معتمدة، تمت مراجعته من قبل أطباء متخصصين لضمان دقة المعلومات

Leave a Reply

Your email address will not be published. Required fields are marked *